CheckMate 153 study: Are age and performance status relevant for immune checkpoint inhibitor efficacy?

Jose Carlos Benitez, Jordi Remon, Benjamin Besse

Résultats de recherche: Contribution à un journal › !!Comment/debate

2 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	S464-S467
journal	Translational Lung Cancer Research
Volume	8
Les DOIs	https://doi.org/10.21037/tlcr.2019.12.26
état	Publié - 1 déc. 2019

Accès au document

@article{b6fc895d3fb64a53b2ea1942cd0d7236,

title = "CheckMate 153 study: Are age and performance status relevant for immune checkpoint inhibitor efficacy?",

author = "Benitez, {Jose Carlos} and Jordi Remon and Benjamin Besse",

year = "2019",

month = dec,

day = "1",

doi = "10.21037/tlcr.2019.12.26",

language = "English",

volume = "8",

pages = "S464--S467",

journal = "Translational Lung Cancer Research",

issn = "2218-6751",

}

TY - JOUR

T1 - CheckMate 153 study

T2 - Are age and performance status relevant for immune checkpoint inhibitor efficacy?

AU - Benitez, Jose Carlos

AU - Remon, Jordi

AU - Besse, Benjamin

PY - 2019/12/1

Y1 - 2019/12/1

UR - http://www.scopus.com/inward/record.url?scp=85083091751&partnerID=8YFLogxK

U2 - 10.21037/tlcr.2019.12.26

DO - 10.21037/tlcr.2019.12.26

M3 - Comment/debate

AN - SCOPUS:85083091751

SN - 2218-6751

VL - 8

SP - S464-S467

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

ER -